FDA Inspection 1221602 — CSL Plasma Inc.

CSL Plasma Inc. — FEI 1047140

The FDA completed an inspection of CSL Plasma Inc. on October 24, 2023 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 24, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)